Abstract Background. Some patients with Cushing's syndrome have nodular adrenal hyperplasia. In most the disease is corticotropin-dependent, but in others it is corti cotropin-independent. The cause of the adrenal hyperpla sia in the latter patients is not known.
T HE most common causes of spontaneous Cush
ing's syndrome are hypersecretion of cortico tropin, from either a pituitary adenoma or a non endocrine tumor, and unilateral adrenal tumors.1 • 2 Although they are generally considered autonomous, adrenal tumors that are responsive to various stimuli, including food, corticotropin, and vasopressin, have been reported. 3-5 Corticotropin-independent Cush ing's syndrome due to nodular hyperplasia6-9 is rare, and its cause is poorly understood, although adrenal stimulation by antibodies has been demonstrated in some cases. 10 • 11 We describe a patient with corticotropin-independ ent Cushing's syndrome, who had low plasma cortisol concentrations during periods of fasting and whose concentrations increased after the ingestion of glu cose, fat, or proteins and the intravenous infusion of gastric inhibitory polypeptide (GIP). As exemplified by this patient and the patient described by Lacroix et al. in an abstract 1 2 and in more detail in the preceding article, 13 Cushing's syndrome can be food-dependent.
CASE REPORT
A 49-year-old woman had a five-year history of fatigue, muscular weakness, and weight gain (total, 8 kg); these symptoms developed during the year after a hysterectomy with oophorectomy. Physical examination revealed that the patient had a round face, interdigital from 164 to 250 µ.g per day ( 453 to 690 nmol per day) and could not be suppressed by a large dose of dexameth asone. Plasma corticotropin concentrations were virtually undetectable at all times. The ingestion of glucose, pro tein, and fat increased plasma cortisol concentrations to 3.6, 2.2, and 4 times the base-line value, respectively; the meal-induced and glucose-induced increases were in hibited by octreotide. The infusion of gastric inhibitory polypeptide (GIP) increased the patient's plasma corti sol concentration to 3.7 times the base-line value, but had no effect in normal subjects. The patient's fasting plasma GIP concentrations were normal both before and after a meal, and there was a close correlation be tween her plasma cortisol and GIP concentrations. Treat ment with octreotide decreased urinary cortisol excretion and ameliorated the clinical manifestations of Cushing's syndrome. Studies were undertaken to determine the responsiveness of the patient's adrenal glands to corticotropin, GIP, mixed meals, carbo hydrate, fat, and protein after a fast lasting overnight or longer. The interval between studies was at least one week. During this period, the patient continued the cyclic transdermal estradiol and oral pro gesterone therapy that had been initiated when she had a hysterec tomy, but she received no other medications. On the morning of each test, she remained supine and had an indwelling catheter placed in a forearm vein to allow repeated blood sampling. The patient subsequently declined to undergo bilateral adrenalectomy Oct. I, 1992 and therefore was treated with octreotide, a somatostatin ana logue, 14 on the basis of its ability to inhibit glucose-induced cortisol secretion in an earlier study. She was treated for 2 weeks with 0.05 mg of octreotide subcutaneously before lunch each day, then for 12 weeks with a dose of 0.05 mg daily before her afternoon snack, and finally with a dose of 0.1 mg three times daily. She was advised to eat normally during treatment.
Conclusions.
Human GIP (Bachem, Bubendorf, Switzerland) was dissolved in saline with I percent albumin, sterilized by membrane filtration, and stored at -20°C until it was used.
METHODS

Normal Subjects
Four normal men ranging in age from 25 to 52 years were studied as described below while being given dexamethasone to suppress corticotropin-dependent cortisol secretion (I mg orally at 4 p.m. and 11 p.m. the day before the test and at 7 a.m. on the morning of the test). Three normal men ranging in age from 27 to 52 years were studied during a 24-hour fast and then after eating a 1130-kcal meal containing 82 g of carbohydrate, 40 g of protein, and 53 g of fat at 8 p.m.
All the studies were approved by the local ethics committee, and the patient and all the normal subjects gave informed consent.
Hormone Assays
Plasma cortisol, corticotropin, aldosterone, and insulin concen trations were measured by commercial radioimmunoassay kits pur chased from Incstar (Stillwater, Minn.), the Nichols Institute (San Juan Capistrano, Calif.), Behring-Calbiochem (San Diego, Calif.), and Pharmacia (lJppsala, Sweden), respectively. Plasma GIP was measured by radioimmunoassay as described previously.1·' The sen sitivity of the corticotropin and GIP assays was I pg and 20 pg, respectively. All plasma samples from each study were measured in duplicate in the same assay. lJ rinary cortisol excretion was meas ured by radioimmunoassay, and urinary 17-hydroxycorticosteroid and 17-ketosteroid excretion was measured by standard colorimet ric methods.
In Vitro Studies
The potential steroidogenic effect of the patient's serum was test tMeasurements were made the day after the administration of I g of metyrapone orally every six hours for one day. The nonnaJ value of 11-dcoxycortisol after metyrapone is 10 to 20 µ.g per deciliter.
.+Measurements were made on the third day of treatment with I mg of dexamethas.one orally at noon, 6 p.m ., and 11 p.m.
for three consecutive days. §Meao;urements were made on the third day of treatment with 2 mg of dexamethasone orally at 8 a.m . • ncxm, 6 p.rn .• and 11 p.m. for three consecutive days.
after she ate a 690-kcal mixed meal ( 116 g of carbohydrate, 27 g of pro tein, and 14 g of fat) at 8 p.m. (Fig.  2A) ; plasma GIP increased from 245 to 1060 ng per liter (49 to 212 pmol per liter). This evening post prandial increase in plasma cortisol did not occur in the three normal men, although their postprandial increase in plasma GIP was pro longed because of the higher fat content of the meal they received (Fig. 2B) .
The administration of both oral (75 g) and intravenous (25 g) glu cose increased the patient's blood glucose and plasma insulin concen trations. By contrast, only the oral Vol. 327 No. 14 FOOD-DEPENDENT CUSHING'S SYNDROME -REZNIK ET AL. administration of glucose was followed by a rise in both plasma cortisol, from 4.1 to 18.0 µ,g per deciliter (113 to 497 nmol per liter), and GIP, from 105 to 1100 ng per liter (21 to 220 pmol per liter) (Fig. 3A) . The oral glucose-induced increase in plasma cortisol and GIP concentrations was inhibited when the patient was given 0.1 mg· of octreotide subcutaneously one hour before the administration of oral glucose ( (Fig. 4A) . In contrast, the same infusions had no effect on plasma cortisol concentrations in four normal subjects who received dexamethasone (Fig. 4B) . These subjects and the patient did have an increase in plasma cortisol in response to corticotropin given 90 minutes after the GIP and glucose infusion was stopped. In all subjects, plasma insulin concentrations increased during the in fusion of GIP, resulting in transient hypoglycemia after both the glucose and GIP infusions were discon tinued. The plasma concentrations of GIP and cortisol were positively correlated (P<0.001) in the samples collected during the studies in which the patient received oral glucose, the protein-based meal, and the fat-based meal.
The human adrenal cells cultured in vitro respond ed to corticotropin in a dose-dependent manner: the mean (±SD) cortisol content in basal medium after 24 hours of incubation was 4.8±0.2 µ,g per milligram of protein, and it was 9.2±0.2, 12.5±2.5, and 27.8±3.3 µ,g per milligram of protein after incubation with 10-12, 10-11, and 10-10 mol of corticotropin per liter, respectively. The patient's serum stimulated cortisol production in these cells (8 . 5± 1.5 and 13.7±2.1 µ,g per milligram of protein after the addition of 20 and 40 µ,l of serum, respectively), as did normal serum (7.2± 1.1 and 11.9± 1.0 µ,g of cortisol per milligram of protein). The IgG (200 µ,g and 400 µ,g) prepared from the patient's serum and from normal serum had no steroidogenic effect. Therefore, this patient's Cush ing's syndrome was not due to adrenal-stimulating immunoglobulins.
Therapeutic Effects of Octreotide
The food-induced increase in plasma cortisol in the patient was inhibited for six hours after a subcutane ous injection of 0.05 mg of octreotide (data not shown). The effectiveness of the subsequent treatment was initially monitored by measurements of urinary cortisol excretion in the evening (6 to 10 .E 50 500
<11
.E 200 500 clinical condition improved: she had lost 5 kg, her well-being and strength improved, and her face be came less round. However, her 24-hour urinary corti sol excretion remained elevated, ranging from 240 to 320 µ,g (662 to 883 nmol) per day. During the fourth month of therapy, clinical signs of Cushing's syn drome recurred; increasing the dose of octreotide to 0.1 mg three times daily resulted in clinical improve ment and the return of urinary cortisol excretion to normal levels ( 100 µ,g [276 nmol] per day).
D1scuss10N
In our patient, Cushing's syndrome, which was manifested by both clinical symptoms and increased urinary cortisol excretion, was clearly due to food in gestion. Her plasma cortisol concentrations were sub normal when she fasted, and they increased after meals, whether she ate mixed meals or meals largely consisting of protein, fat, or carbohydrate. The in creases in plasma cortisol concentrations were not me diated by corticotropin secretion, since plasma corti cotropin concentrations were virtually undetectable at all times and dexamethasone did not suppress plasma cortisol concentrations or urinary cortisol excretion. Plasma cortisol concentrations increased in response to the administration of oral glucose, but not intrave nous glucose, and this increase was suppressed by oc treotide, a somatostatin analogue that is known to de crease the plasma concentrations of various peptides in patients with endocrine tumors of the digestive tract.17 These results strongly suggested that the adre nal glands of this patient were stimulated by some hormone or hormones of the gastrointestinal tract. As in the report by Lacroix et al., 12 GIP was a likely candidate, since the secretion of this peptide is nor mally stimulated by the ingestion of protein, fat, and glucose.18 • 19 The intravenous infusion of GIP resulted in an increase in the plasma cortisol concentrations of the patient, but not of four normal subjects receiving dexamethasone. GIP stimulated insulin secretion in all subjects, as previously reported. 2 0
The mechanism of the GIP-mediated adrenal stim ulation in this patient is not known. Hypersecretion of GIP is unlikely, since the patient's endogenous plasma GIP concentrations were normal, both during peri ods of fasting and after meals. The most likely expla nation is direct or indirect stimulation of the adre nal glands by GIP due to aberrant sensitivity of the glands to this peptide or to a metabolite. This unex pected sensitivity to GIP must be due to the presence of ectopic GIP receptors on the adrenal glands that are not expressed in normal subjects, or to abnormal corticotropin receptors capable of binding GIP as well as corticotropin. Whether or not other peptides can stimulate our patient's adrenal glands is unknown. The failure of lysine vasopressin, glucagon, insulin, and pentagastrin to produce such an effect does not rule out the possibility that some other known or un known peptides contribute to the patient's adrenal hypersecretion.
Whatever the mechanism involved, it must differ from that which elicits the food-dependent increase in plasma cortisol concentrations that occurs in some normal subjects. Although some investigators have not found any effect of meals on cortisol secretion in normal subjects,21•23 others have found a lunch-related increase in plasma cortisol concentrations. 2 4-2 6 This in crease is due to the ingestion of proteins, mainly those containing tyrosine and tryptophan; fat and carbohy drate have no discernible effect. 27 The sight and taste of food, without ingestion, do not evoke an increase in plasma cortisol. 27 This after-lunch cortisol secretion in normal subjects is suppressed by dexamethasone28 and is therefore a corticotropin-dependent phenom enon. 29 Gastrin-releasing peptide may participate in the corticotropin-dependent postprandial peak, since this peptide and its receptors are present in the hypo thalamus, and the concentrations of both corticotro pin and cortisol are increased, in a dose-dependent manner, by the infusion of this peptide. 30 The increase in plasma cortisol concentrations induced by the intravenous infusion of vasoactive intestinal poly peptide in patients with Cushing's disease was also related to corticotropin secretion by the pituitary ad enomas, and it disappeared after successful adeno mectomy. 31 The ability of octreotide to block the increase in plasma cortisol concentrations induced by oral glu cose in our patient led us to use this drug as an alterna tive to bilateral adrenalectomy. We believed that this treatment was logical and permissible in our patient, at least for some time, since her Cushing's syndrome was mild and she declined to undergo adrenalectomy.
The initial treatment with a single injection before lunch or in the afternoon was designed to reproduce an almost normal diurnal cycle of cortisol secretion by maintaining the meal-stimulated morning peak and inhibiting any cortisol increase later in the day. How ever, as a result of insufficient cortisol suppression, we had to increase the dose to 0.1 mg three times daily.
With this regimen, the patient's urinary cortisol excre tion decreased to the upper limit of normal. Therefore, octreotide had an incomplete effect in this patient, and its use as a long-term treatment remains questionable.
